The first issue of Volume 2 (January/February 2008) explores the results of the “Oats at 10 Years” study, marking the 10th anniversary of the U.S. Food and Drug Administration claim that oats, as part of an overall heart healthy diet, could lower the risk of heart disease. The article, written by Mark B. Andon, PhD, and James W.

A protein that helps prevent a woman’s body from rejecting a fetus may also play an important role in enabling pancreatic cancer cells to evade detection by the immune system, allowing them to spread in the body.

Cold Spring Harbor Laboratory’s (CSHL) researcher Raffaella Sordella, Ph.D. was awarded $100,000 by Joan’s Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer. The two-year grant will fund CSHL’s pioneering lung cancer research involving a new class of genetic mutations that appear to be a trigger in non-small cell lung cancer, the leading cause of cancer deaths in the United States.

Cold Spring Harbor Laboratory (CSHL) has announced that CSHL researcher Senthil Muthuswamy, Ph.D., received two grants totaling over $32,000 from the Joni Gladowsky Breast Cancer Foundation to further the development of alternative breast cancer treatment strategies. Dr.

Colombia’s Minister of Social Protection, Diego Palacio Betancourt, presented Children’s Hospital of Pittsburgh of UPMC’s Heart Center Chief of the Division of Cardiac Intensive Care Ricardo A. Munoz, MD, FAAP, FCCM, with the prestigious Jorge Bejarano Civic Cross Medal.During a visit to the Fundacion Valle de Lili last month, Dr.

Two Hebrew University of Jerusalem researchers, Prof. Howard Cedar and Prof. Aharon Razin, have been awarded the 2008 Wolf Prize in Medicine for their fundamental contributions to the control of gene expression and cancer research.Minister of Education Prof.

A study co directed by the Universidad Complutense de Madrid and La Paz hospital in Madrid identifies a protein of high expression in cells located at the tumour boundary that could play an essential role in the evolution of tumours and their invasive potential.

ETHICON, INC. announced that the U.S. Food and Drug Administration has granted an expanded indication for EVICEL” Fibrin Sealant (Human). The product is the first fibrin sealant to be indicated as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques is ineffective or impractical. EVICEL” is the only all-human plasma-derived fibrin sealant commercially available in the U.S.

UroToday.com - Androgen deprivation therapy (ADT) is associated with metabolic syndrome, which includes the development of type II diabetes mellitus and coronary artery disease. In the October 17, 2007 issue of the Journal of the National Cancer Institute evaluated whether ADT induced metabolic changes result in an increased risk of cardiovascular (CV) death. The longitudinal, observational prostate cancer registry CaPSURE was used to study a cohort of 4,892 men.

Scientists at Aberdeen’s Rowett Research Institute have shown that a high protein, low carbohydrate diet is most effective at reducing hunger and promoting weight loss, at least in the short term. Their work has just been published in the American Journal of Clinical Nutrition. Healthy, obese men were given two different diets during their stay in the Rowett’s specialised Human Nutrition Unit.